December 2009 - Present

Assigned Products;

1. Levemir (Insulin Detemir, once daily basal insulin analogue)
2. NovoMix 30 (Bi-Phasic Aspart, premix insulin analogue)
3. NovoRapid (Insulin Aspart, rapid acting Insulin analogue)
4. NovoSeven (rFVIIa, haemostatic agent)
5. Norditopin Nordilet (Somatropin, First liquid Growth Hormone in multi-dose disposable pen)

Key Responsibilities;

# To develop comprehensive strategic marketing plans for assigned portfolios after profound market analysis on yearly basis.
# To develop marketing strategies towards the identified physicians & patient segments, resulting from the findings in SWOT, market archetype, competitors’ analysis and disease/product life cycle.
# To plan and implement tactics like local & intl. symposia/customer meetings, campaigns, public relations (advisory board & advocacy groups), CME, publication and other marketing & communications tools.
# By using IDF & WFH guidelines regularly observe World Diabetes Day on 14th November and World Haemophilia Day on 17th April in Pakistan.
# To develop promotional & educational materials for targeted physicians (Adult and Paediatric Endocrinilogists, Haematologist, Paediatritians, Physicians and GPs),patients, pharmacists& caregivers.
# To develop & execute processes for customers targeting, frequency and message development
for the sales force.
# To conduct cycle meetings and National Sales conference for the sales force.
# Give training to internees/marketing associates/sales managers.

Key Achievements;

# Consistent market share development in MI portfolio and achieved leadership position in premix
analogue segment (Source IMS)
# Launched Novo Helpline (0800-SUGAR)
# Re launched new patients starter kit Campaign
# Successfully arranged and executed National Sales Conference and 1st Cycle meeting with
robust marketing acumen
# Successfully role out Levemir’s &-Campaign in Pakistan
# Develop new promotional material for MI products